<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03207022</url>
  </required_header>
  <id_info>
    <org_study_id>ECM 4 (aa)</org_study_id>
    <nct_id>NCT03207022</nct_id>
  </id_info>
  <brief_title>Comparison Between Epinephrine and Clonidine as Adjuvants to Lidocaine in Axillary Brachial Plexus Block.</brief_title>
  <official_title>Comparison Between Epinephrine and Clonidine as Adjuvants to Lidocaine in Ultrasound Guided Axillary Brachial Plexus Block.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cork University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cork University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adjuncts to local anaesthetics for the peripheral nerve blocks such as epinephrine, clonidine&#xD;
      and opioids have been widely used to enhance quality, duration of anaesthesia and&#xD;
      postoperative analgesia. Clonidine, an α2-adrenergic agonist, when combined with local&#xD;
      anaesthetics in axillary brachial plexus block has shown to decrease block onset time and&#xD;
      prolong the duration of anaesthesia.&#xD;
&#xD;
      We propose to compare the effects of combining both adjuvants to 20 mL of lidocaine 2% on the&#xD;
      onset of ultrasound guided axillary brachial plexus block.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Using a 20 mL lidocaine 2% when combined with epinephrine 1:200 000 and clonidine 1 µg/kg&#xD;
      will shorten the onset time of sensory block when compared to lidocaine 2% with epinephrine&#xD;
      1:200 000 alone in ultrasound guided axillary brachial plexus block for elective upper limb&#xD;
      surgeries.&#xD;
&#xD;
      It is a prospective, randomized, observer blinded study. With institutional ethical approval&#xD;
      and having obtained written informed consent from each, 24 patients will be studied.&#xD;
&#xD;
      Randomisation and blinding:&#xD;
&#xD;
      Using a computer generated and sealed envelope technique, 24 patients will be randomized in&#xD;
      to one of two groups to receive ultrasound guided axillary brachial plexus block.&#xD;
&#xD;
      Group 1:&#xD;
&#xD;
      Patients will receive 20 ml of lidocaine 2% with epinephrine and 2 ml of 0.9% normal saline.&#xD;
&#xD;
      Group 2:&#xD;
&#xD;
      Patients will receive 20 ml of lidocaine 2% with epinephrine and clonidine 1µg/kg in 2 ml of&#xD;
      0.9% normal saline.&#xD;
&#xD;
      Sample size and Statistical analysis:&#xD;
&#xD;
      Sample size will be based on onset of block. Kaabachi et al16 found a sensory onset of&#xD;
      axillary brachial plexus block (with 30 ml of lidocaine 1.5%) of 9 (SD, 3) mins. The sample&#xD;
      size required to have an 90% probability of detecting a decrease in the onset time by 40%&#xD;
      (level of significance 0.05)) will be 12 patients per group using an unpaired student's t&#xD;
      test.&#xD;
&#xD;
      Anaesthetic procedure:&#xD;
&#xD;
      Having established intravenous access, standard anaesthetic monitoring will be applied.&#xD;
      Sedation with midazolam will be administered as clinically indicated (to a maximum of 3 mg).&#xD;
      The operative arm will be abducted and externally rotated with elbow flexed at 90 degrees.&#xD;
      Under strict aseptic condition, ultrasound guided axillary brachial plexus block will be&#xD;
      performed. Having identified musculocutaneous, median, radial and ulnar nerves, a 50mm&#xD;
      22-gauge ultrauplex short bevel insulated needle will be used with in-plane approach to block&#xD;
      each nerve. 20 mL of Lidocaine 2% with epinephrine and 2ml of 0.9% Nacl(group 1) or clonidine&#xD;
      1µg/kg in 2 ml of 0.9% Nacl(group 2) will be divided equally among the 4 nerves. All blocks&#xD;
      will be performed by single operator experienced in the ultrasound peripheral nerve blocks.&#xD;
&#xD;
      Block assessment:&#xD;
&#xD;
      When the block procedure has been completed, a blinded observer will assess the onset of&#xD;
      sensory and motor block in the innervation of each nerve every 2.5 mins until complete&#xD;
      sensory and motor block is achieved or 30 mins have elapsed . Complete sensory block is&#xD;
      defined as absent sensation to cold and pinprick and complete motor block is defined as motor&#xD;
      score ≤2. Each nerve distribution will be individually assessed. Onset time will be measured&#xD;
      from conclusion of the block (t=0) to attainment of (surgical anaesthesia) complete sensory&#xD;
      and motor block. Block will be deemed failure if sensory and motor block has not been&#xD;
      achieved at 30 mins in one or more of the four nerve distribution. In case of failure, an&#xD;
      additional rescue block or conversion to general anaesthesia will be performed. DATA from&#xD;
      these patients will be analysed separately.&#xD;
&#xD;
      Intraoperative period:&#xD;
&#xD;
      All patients will receive 1 g of paracetamol and diclofenac 75 mg iv during surgery. In case&#xD;
      of patients discomfort rescue analgesia in the form of fentanyl 25 micrograms aliquots IV&#xD;
      will be administered to a maximum of 100 micrograms.&#xD;
&#xD;
      Postoperative period:&#xD;
&#xD;
      Upon arrival to recovery room, sensory and motor function will be assessed every 15 mins by a&#xD;
      blinded observer. Assessment will be performed for each nerve separately. Block regression is&#xD;
      defined as a return of sensation to cold and pinprick with motor power score ≥3 in any nerve&#xD;
      region. Time to first request for postoperative analgesia will be noted. Postoperative&#xD;
      analgesia will be prescribed as paracetamol 1 g 6 hourly and diclofenac sodium 75 mg 12&#xD;
      hourly. Oxycodone 5-10 mg orally 4-6 hourly will be administered as rescue analgesia.&#xD;
&#xD;
      Heart rate, arterial blood pressure, spo2 and sedation score (1=awake and alert, 2= sedated,&#xD;
      responding to verbal stimulus, 3= sedated, responding to mild physical stimulus and&#xD;
      4=sedated, responding to moderate to severe physical stimulus) will be recorded&#xD;
      intraoperatively every 5 mins and every 15 mins postoperatively for the first 4 hours.&#xD;
      Hypotension and bradycardia, defined as 20% decrease in blood pressure and heart rate in&#xD;
      relation to preblock value, will be recorded.&#xD;
&#xD;
      Primary Outcome:&#xD;
&#xD;
      The primary outcome will be onset of sensory block.&#xD;
&#xD;
      Secondary Outcomes:&#xD;
&#xD;
        1. Onset of motor block.&#xD;
&#xD;
        2. Duration of sensory and motor block&#xD;
&#xD;
        3. The quality of block intra operatively&#xD;
&#xD;
        4. The incidence of side effects in both groups. : sedation, hypotension, nausea,&#xD;
           dizziness, tinnitus, vomiting convulsions or arrthymia&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 11, 2014</start_date>
  <completion_date type="Actual">July 14, 2016</completion_date>
  <primary_completion_date type="Actual">July 14, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Onset of Sensory Block</measure>
    <time_frame>1 day</time_frame>
    <description>Time taken for onset of sensory axillary brachial plexus block</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Onset of Motor Block.</measure>
    <time_frame>1 day</time_frame>
    <description>time taken for onset of motor block of ultrasound guided axillary brachial plexus block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Sensory and Motor Block</measure>
    <time_frame>1 day</time_frame>
    <description>Total duration of sensory block of ultrasound guided axillary brachial plexus block</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Brachial Plexus Blockade</condition>
  <arm_group>
    <arm_group_label>lidocaine 2% with normal saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with 2 ml of 0.9% normal saline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lidocaine 2% with clonidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with clonidine 1µg/kg in 2 ml of 0.9% normal saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>axillary brachial plexus block</intervention_name>
    <description>ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
    <arm_group_label>lidocaine 2% with clonidine</arm_group_label>
    <arm_group_label>lidocaine 2% with normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA 1-2&#xD;
&#xD;
          -  Patients age &gt;18 years&#xD;
&#xD;
          -  Undergoing elective upper limb (forearm, wrist or hand) surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications to regional anaesthesia&#xD;
&#xD;
          -  Hypersensitivity to amide local anaesthetics.&#xD;
&#xD;
          -  Chronic pain&#xD;
&#xD;
          -  Language barrier&#xD;
&#xD;
          -  Neuromuscular disorders or peripheral neuropathy&#xD;
&#xD;
          -  H/o postural hypotension or autonomic dysfunction.&#xD;
&#xD;
          -  Patients with a known sensitivity for local anaesthetics&#xD;
&#xD;
          -  Body mass index &gt; 35&#xD;
&#xD;
          -  History of hepatic and renal insufficiency&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Cognitive or psychiatric disorder&#xD;
&#xD;
          -  Cardiac conduction abnormality.&#xD;
&#xD;
          -  Anti arrythmic or adrenergic medications.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anil Ranganath</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cork University Hospital</affiliation>
  </overall_official>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 7, 2017</study_first_submitted>
  <study_first_submitted_qc>June 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2017</study_first_posted>
  <results_first_submitted>August 7, 2021</results_first_submitted>
  <results_first_submitted_qc>August 7, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 2, 2021</results_first_posted>
  <last_update_submitted>August 7, 2021</last_update_submitted>
  <last_update_submitted_qc>August 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cork University Hospital</investigator_affiliation>
    <investigator_full_name>Dr Anil Ranganath</investigator_full_name>
    <investigator_title>Dr (Fellow in Regional Anaesthesia)</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Assessed for eligibility: n = 50 Excluded 26&#xD;
Not meeting inclusion criteria n= 8&#xD;
Declined to participate n= 18 Randomized n = 24</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Lidocaine 2% With Normal Saline</title>
          <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with 2 ml of 0.9% normal saline.&#xD;
axillary brachial plexus block: ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
        </group>
        <group group_id="P2">
          <title>Lidocaine 2% With Clonidine</title>
          <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with clonidine 1µg/kg in 2 ml of 0.9% normal saline.&#xD;
axillary brachial plexus block: ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Lidocaine 2% With Normal Saline</title>
          <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with 2 ml of 0.9% normal saline.&#xD;
axillary brachial plexus block: ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
        </group>
        <group group_id="B2">
          <title>Lidocaine 2% With Clonidine</title>
          <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with clonidine 1µg/kg in 2 ml of 0.9% normal saline.&#xD;
axillary brachial plexus block: ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="24"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.4" spread="10.6"/>
                    <measurement group_id="B2" value="42.3" spread="8.6"/>
                    <measurement group_id="B3" value="41.9" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Ireland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Onset of Sensory Block</title>
        <description>Time taken for onset of sensory axillary brachial plexus block</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lidocaine 2% With Normal Saline</title>
            <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with 2 ml of 0.9% normal saline.&#xD;
axillary brachial plexus block: ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine 2% With Clonidine</title>
            <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with clonidine 1µg/kg in 2 ml of 0.9% normal saline.&#xD;
axillary brachial plexus block: ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
          </group>
        </group_list>
        <measure>
          <title>Onset of Sensory Block</title>
          <description>Time taken for onset of sensory axillary brachial plexus block</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="8.8" upper_limit="12.5"/>
                    <measurement group_id="O2" value="5" lower_limit="5" upper_limit="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Onset of Motor Block.</title>
        <description>time taken for onset of motor block of ultrasound guided axillary brachial plexus block</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lidocaine 2% With Normal Saline</title>
            <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with 2 ml of 0.9% normal saline.&#xD;
axillary brachial plexus block: ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine 2% With Clonidine</title>
            <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with clonidine 1µg/kg in 2 ml of 0.9% normal saline.&#xD;
axillary brachial plexus block: ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
          </group>
        </group_list>
        <measure>
          <title>Onset of Motor Block.</title>
          <description>time taken for onset of motor block of ultrasound guided axillary brachial plexus block</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" lower_limit="6.3" upper_limit="7.5"/>
                    <measurement group_id="O2" value="5" lower_limit="2.5" upper_limit="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Sensory and Motor Block</title>
        <description>Total duration of sensory block of ultrasound guided axillary brachial plexus block</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lidocaine 2% With Normal Saline</title>
            <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with 2 ml of 0.9% normal saline.&#xD;
axillary brachial plexus block: ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine 2% With Clonidine</title>
            <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with clonidine 1µg/kg in 2 ml of 0.9% normal saline.&#xD;
axillary brachial plexus block: ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Sensory and Motor Block</title>
          <description>Total duration of sensory block of ultrasound guided axillary brachial plexus block</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="165" spread="24.1"/>
                    <measurement group_id="O2" value="218.3" spread="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 DAY</time_frame>
      <desc>The incidence of side effects in both groups. : sedation, hypotension, nausea, us, vomiting convulsions or arrythmia</desc>
      <group_list>
        <group group_id="E1">
          <title>Lidocaine 2% With Normal Saline</title>
          <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with 2 ml of 0.9% normal saline.&#xD;
axillary brachial plexus block: ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
        </group>
        <group group_id="E2">
          <title>Lidocaine 2% With Clonidine</title>
          <description>Patients will receive ultrasound guided axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine mixed with clonidine 1µg/kg in 2 ml of 0.9% normal saline.&#xD;
axillary brachial plexus block: ultrasound guided axillary brachial plexus block with 20 ml local anaesthetic lidocaine with epinephrine and clonidine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Anil Ranganath</name_or_title>
      <organization>Cork University Hospital</organization>
      <email>drmrak.2@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

